We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
Cap. Flow
+$1.47B
Cap. Flow %
10.47%
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$177M
2
LOW icon
Lowe's Companies
LOW
+$108M
3
STJ
St Jude Medical
STJ
+$95.4M
4
NWL icon
Newell Brands
NWL
+$88.6M
5
STZ icon
Constellation Brands
STZ
+$87.2M

Top Sells

Rank Stock Value
1
EMC
EMC CORPORATION
EMC
+$136M
2
UNH icon
UnitedHealth
UNH
+$99.3M
3
PYPL icon
PayPal
PYPL
+$85.4M
4
SBUX icon
Starbucks
SBUX
+$78.1M
5
CI icon
Cigna
CI
+$64.7M

Sector Composition

Rank Sector Weight
1 Healthcare 20.63%
2 Consumer Discretionary 12.48%
3 Communication Services 12.09%
4 Technology 9.72%
5 Industrials 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNO icon
726
Vornado Realty Trust
VNO
$7.47B
$950K 0.01%
+11,607
New +$962K
JBHT icon
727
JB Hunt Transport Services
JBHT
$27.1B
$949K 0.01%
11,690
-187,415
-94% -$15.3M
TROW icon
728
T. Rowe Price
TROW
$25B
$946K 0.01%
+14,233
New +$992K
NTNX icon
729
Nutanix
NTNX
$14.9B
$925K 0.01%
+25,000
New +$925K
NKE icon
730
Nike
NKE
$61.9B
$921K 0.01%
+17,494
New +$988K
RBA icon
731
RB Global
RBA
$20.8B
$903K 0.01%
+25,735
New +$839K
P
732
Everpure Inc
P
$24.8B
$895K 0.01%
+66,060
New +$824K
ESL
733
DELISTED
Esterline Technologies
ESL
$880K 0.01%
+11,574
New +$812K
GRFS
734
Grifois
GRFS
$5.16B
$868K 0.01%
+54,347
New +$895K
HST icon
735
Host Hotels & Resorts
HST
$16.8B
$858K 0.01%
+55,117
New +$945K
MODV
736
DELISTED
ModivCare
MODV
$856K 0.01%
17,594
-11,119
-39% -$521K
WES
737
DELISTED
Western Gas Partners Lp
WES
$846K 0.01%
+15,370
New +$770K
NBLX
738
DELISTED
Noble Midstream Partners LP
NBLX
$843K 0.01%
+30,208
New +$814K
CSTM icon
739
Constellium
CSTM
$3.96B
$840K 0.01%
116,774
ELGX
740
DELISTED
Endologix Inc
ELGX
$839K 0.01%
+6,558
New +$839K
WBD icon
741
Warner Bros
WBD
$64.6B
$830K 0.01%
30,829
-127,407
-81% -$3.27M
DIS icon
742
Walt Disney
DIS
$165B
$828K 0.01%
+8,916
New +$854K
RUTH
743
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$825K 0.01%
58,402
-34,043
-37% -$521K
RP
744
DELISTED
RealPage, Inc.
RP
$823K 0.01%
+32,007
New +$797K
GLOB icon
745
Globant
GLOB
$1.35B
$800K 0.01%
+18,981
New +$775K
LZB icon
746
La-Z-Boy
LZB
$1.59B
$797K 0.01%
+32,448
New +$913K
MCD icon
747
McDonald's
MCD
$188B
$796K 0.01%
+6,902
New +$818K
SBNY
748
DELISTED
Signature Bank
SBNY
$794K 0.01%
+6,700
New +$807K
IMS
749
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
$789K 0.01%
+25,184
New +$736K
AD
750
Array Digital Infrastructure
AD
$3.02B
$781K 0.01%
+21,483
New +$827K

Similar funds

Marshall Wace's Q3 2016 Portfolio in Review

As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.

  • Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
  • Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
  • Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
  • Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
  • Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
  • Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.

Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.